Insights into the molecular changes of adipocyte dedifferentiation and its future research opportunities

Mingheng Xue1, Yunjun Liao1, Wenqing Jiang1

  • 1Department of Plastic and Cosmetic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.

Journal of Lipid Research
|September 20, 2024
PubMed

Insights

Mature fat cells can dedifferentiate into fibroblast-like cells (DFAT cells), offering potential for stem cell therapy. This review details the epigenetic, genetic, and phenotypic changes involved in DFAT cell dedifferentiation.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Regenerative Medicine

Background:

  • Mature adipocytes were traditionally considered terminally differentiated.
  • Recent research shows adipocytes can dedifferentiate into fibroblast-like cells, termed dedifferentiated fat (DFAT) cells.
  • DFAT cells exhibit stem cell-like properties, suggesting therapeutic potential.

Purpose of the Study:

  • To explore the epigenetic, genetic, and phenotypic changes during adipocyte dedifferentiation.
  • To identify potential clinical targets for regulating DFAT cell processes.
  • To discuss current applications and challenges in DFAT cell research.

Main Methods:

  • Review of existing literature on adipocyte dedifferentiation.
  • Analysis of epigenetic modifications (e.g., DNA methylation, histone modification).
  • Examination of genetic factors and signaling pathways involved.

Main Results:

  • Dedifferentiation involves significant epigenetic reprogramming and altered gene expression.
  • DFAT cells display plasticity, resembling pluripotent stem cells.
  • Specific molecular pathways regulating dedifferentiation are being elucidated.

Conclusions:

  • DFAT cells represent a promising, accessible cell source for regenerative medicine.
  • Understanding the regulatory mechanisms is crucial for clinical translation.
  • Further research is needed to overcome challenges in DFAT cell application.

Related Concept Videos